Acceptability of placebo multiparticulate formulations in children and adults-Reference-Cited by-同舟云学术

Acceptability of placebo multiparticulate formulations in children and adults

Published:2018-06-15 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lopez Felipe L.,Mistry Punam,Batchelor Hannah K.,Bennett Joanne,Coupe Alastair,Ernest Terry B.,Orlu Mine,Tuleu Catherine

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-27446-6.pdf

Reference34 articles.

1. EMA. Guideline on pharmaceutical development of medicines for paediatric use. at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/07/WC500147002.pdf (2013).

2. Mistry, P. & Batchelor, H. Evidence of acceptability of oral paediatric medicines: a review. J. Pharm. Pharmacol. https://doi.org/10.1111/jphp.12610 (2016).

3. WHO. Development of paediatric medicines: points to consider in formulation (2012).

4. Thomson, S. A. et al. Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics 123, 235–8 (2009).

5. Klingmann, V. et al. Acceptability of Uncoated Mini-Tablets in Neonates—A Randomized Controlled Trial. J. Pediatr. https://doi.org/10.1016/j.jpeds.2015.07.010 (2015).

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation and Evaluation of Polysaccharide Microparticles for the Controlled Release of Propranolol Hydrochloride;Pharmaceutics;2024-06-11

2. Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs;Acta Pharmaceutica;2024-05-30

3. Discrimination of cellulose microparticles in rats;Physiology & Behavior;2024-04

4. The difficult decision of buying food for others: Which puree will my baby like?;Food Research International;2024-03

5. Investigating the prilling/vibration technique to produce gastric-directed drug delivery systems for misoprostol;International Journal of Pharmaceutics;2024-02